NOTICE AND WAIVERNotice and Waiver • August 27th, 2021 • Athyrium Capital Management, LP • Services-medical laboratories
Reference is made to that certain Fourth Amended and Restated Investors’ Rights Agreement, dated as of August 27, 2019, as amended by Amendment No. 1 on November 10, 2020, as further amended by Amendment No. 2 on December 7, 2020, and as further amended by Amendment No. 3 on May 31, 2021, by and among Progenity, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Notice and Waiver (the “Waiver”) as an “Investor” (the “Investors’ Rights Agreement”).
NOTICE AND WAIVERNotice and Waiver • November 26th, 2021 • Athyrium Opportunities 2020 LP • Services-medical laboratories
Reference is made to that certain Fourth Amended and Restated Investors’ Rights Agreement, dated as of August 27, 2019, as amended by Amendment No. 1 on November 10, 2020, as further amended by Amendment No. 2 on December 7, 2020, and as further amended by Amendment No. 3 on May 31, 2021, by and among Progenity, Inc., a Delaware corporation (the “Company”), and certain investors party thereto (the “Investors’ Rights Agreement”).
EXHIBIT 10.4 NOTICE AND WAIVER THIS NOTICE AND WAIVER (the "Waiver") dated as of September 30, 2002, by and among KPMG CONSULTING, INC., a Delaware corporation (the "Borrower"), the Guarantors, the Banks, and PNC BANK, NATIONAL ASSOCIATION, as...Notice and Waiver • November 15th, 2002 • Bearingpoint Inc • Services-management consulting services • New York
